Alvaro Köhn-Luque

Senior scientist @OCBE_UniOslo, mathematician working on personalized cancer medicine using mechanistic modeling, machine leaning or combinations of both.

[Alvaro Köhn-Luque @AlvaroKohn]

I am transitioning from dark to blue skies 🦋 and I will shortly close this account. I hope to see you in the other side 🙌

[Alvaro Köhn-Luque @AlvaroKohn]

Don’t miss this great summary of our latest preprint

[Youness @YounessAzimzade]

If you are interested in immune cells in tumors and their impact on clinical outcomes, our latest work might interest you: https://t.co/1dMjV63utd. We pose a simple question: how is the abundance of different cell types associated with treatment response and relapse? 1/n

[BIRS @BIRS_Math]

Leah Edelstein-Keshet (University of British Columbia), Modeling & simulating single cell motility optogenetic experiments https://t.co/v46wOXAmMb

[Vivli @VivliCenter]

Congratulations to @MyelomaOslo on your public disclosure, “Relapse prediction in multiple myeloma patients treated with isatuximab, carfilzomib, and dexamethasone.” We’re proud to facilitate your access to data #ClinicalResearch https://t.co/QEwhiueWxw

[RESCUER @RESCUER2020]

Mads Haugen presenting at Lewis-Sigler institute work from his group and RESCUER
@YounessAzimzade @AlvaroKohn @freeges

[Chris Tape @christophertape]

Excellent review from @mariangelaruss2 @BardelliLab discussing our current understanding of drug-tolerant persister cells in cancer.

https://t.co/iBDEuhZMgs

[Bartomeu Colom @Bartomeu_Colom]

'Mechanisms that clear mutations drive field cancerization in mammary tissue'
https://t.co/8L7BfInxu2

[Alvaro Köhn-Luque @AlvaroKohn]

@mtmdphd @VincentRK @TheLancetOncol Sure, but what you think is the effect of low dose on the cancer compared to high dose?

[Alvaro Köhn-Luque @AlvaroKohn]

@mtmdphd @VincentRK @TheLancetOncol Is any mechanism mentioned in the paper? Toxicity? That would be important but not so interesting as I thought it could be…

[Mathoncoblog @mathoncoblog]

Just on time for labor day weekend (for those of you State-side)
@mathoncbro writes about mechanistic learning, the best of two worlds based on a paper by @jmetzcar @MathCancer @AlvaroKohn @Jutzeler_Cathy and Sara Bruningk:
https://t.co/w2t0Gk0ViA
#MachineLearning #MathOnco

[Sandy Anderson @ara_anderson]

Excited to share the fruits of a new collaboration with @AguadeGuim and @ricard_sole on: Modeling tumors as complex ecosystems. This perspective is open access with almost 230 references - out now in @iScience_CP https://t.co/eIXAHY3fiZ

[Oxford Mathematics @OxUniMaths]

Oxford Mathematician and Fellow of @StJohnsOx Philip Maini has been awarded the Sylvester Medal by the @royalsociety for his contributions to mathematical biology.

Pretty good teacher too.

https://t.co/On8KkwubXl
Photo: Robert Taylor/St John's

[Alvaro Köhn-Luque @AlvaroKohn]

Don’t miss these remarks of our review paper by the amazing @mathoncbro 🙌 thank you 🙏 @OCBE_UniOslo #mathonco

[Jeffrey West @mathoncbro]

This paper has my vote for Most Interesting & Provocative new ideas in "philosophy of modeling" in the last several years:
https://t.co/cim0zqNqkg

My summary: 🧵🧵🧵

[Niko McCarty. @NikoMcCarty]

30 Essays to Make You Love Biology

Day 1. "I should have loved biology" by James Somers.

"It was only in college, when I read Douglas Hofstadter’s Gödel, Escher, Bach, that I came to understand cells as recursively self-modifying programs."

[Dr. Bernadette Stolz @StolzBernadette]

Great first day at #ECMTB24 including interesting talks on integrating mechanistic models and machine learning in mathematical oncology by @guillelorenzogz and @SBruningk.

[Pejman Shojaee @pejmanshojam31]

Attended to the first session „mechanistic learning in mathematical oncology“ organised by @AlvaroKohn.
Babis @M3sBiomath gave his talk on making clinical predictions without understanding everything.
@ecmtb2024 #Toledo #math_onco

[ECMTB 2024 @ecmtb2024]

Dear ECMTB2024 participants,

The 13th Edition of the European Conference on Mathematical and Theoretical Biology https://t.co/YBMm9BXYCk is just around the corner so, before arriving in Toledo, we would like to give you some indications.

🧵(1/10)

[Clinical Cancer Research @CCR_AACR]

Read the article: Computational model predicts patient outcomes in Luminal B breast cancer treated with endocrine therapy and CDK4/6 inhibition.
https://t.co/2uUkRVbyMu

[Alvaro Köhn-Luque @AlvaroKohn]

Thanks for highlighting our recent @CCR_AACR paper predicting patient outcomes in breast cancer treated with endocrine therapy and CDK4/6 inhibition. Also really looking forward to read the ctDNA paper of #JasmineFoo et al. And congratulations on the 300 #MathOnco edition!

[Jeffrey West @mathoncbro]

This week in #MathOnco 300!

ecological interactions, predictive modeling, CT DNA kinetics, and more...

Art: Artist: Mark Chaplain (@mcapellanus), Nikos Sfakianakis, Dimitris Katsaounis, Nicholas Harbour, Thomas Williams

Signup: https://t.co/RaB4tQViSH